Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 14/20 | 0.40 |
| ▸ | F10 | P00742 | 3/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.33 |
| ▸ | SIK1 | P57059 | 1/20 | 0.32 |
| ▸ | SIK2 | Q9H0K1 | 1/20 | 0.32 |
| ▸ | SIK3 | Q9Y2K2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26100976 | 1.00 | TYK2 (0.40) | TYK2F10PDE4DJAK2PTK2 | |
| SCHEMBL30392380 | 0.89 | TYK2 (0.40) | TYK2F10PDE4D | |
| SCHEMBL26100095 | 0.89 | TYK2 (0.40) | TYK2F10PDE4D | |
| SCHEMBL26102625 | 0.87 | TYK2 (0.41) | TYK2F10PDE4D | |
| SCHEMBL30392501 | 0.87 | TYK2 (0.41) | TYK2F10PDE4D | |
| SCHEMBL30392350 | 0.86 | TYK2 (0.39) | TYK2JAK2PTK2 | |
| SCHEMBL26100229 | 0.86 | TYK2 (0.39) | TYK2JAK2PTK2 | |
| SCHEMBL26100483 | 0.83 | F10 (0.36) | TYK2F10PDE1B | |
| SCHEMBL30392536 | 0.83 | TYK2 (0.38) | TYK2PDE4D | |
| SCHEMBL26097861 | 0.83 | TYK2 (0.38) | TYK2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423086-A1 | TYK2 DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023076161-A1 | TYK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |